This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an eLetter
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by FENWICK, E.
Right arrow Articles by BYFORD, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by FENWICK, E.
Right arrow Articles by BYFORD, S.
The British Journal of Psychiatry (2005) 187: 106-108
© 2005 The Royal College of Psychiatrists

EDITORIALS

A guide to cost-effectiveness acceptability curves

ELISABETH FENWICK, PhD

Department of Economics and Related Studies, University of York

SARAH BYFORD, MSc

Centre for the Economics of Mental Health, Institute of Psychiatry, De Crespigny Park, London, UK

Correspondence: Dr Elisabeth Fenwick, Department of Economics and Related Studies, University of York, Heslington, York YO10 5DD, UK. Tel: +44(0) 1904 321451; fax: +44(0) 1904 321402; e-mail: ealf100{at}york.ac.uk

Declaration of interest None.

ABSTRACT

Use of cost-effectiveness acceptability curves, as a method for summarising information on uncertainty in cost-effectiveness, has become widespread within applied studies. This includes several studies in the mental health field. This editorial uses examples from recent papers to illustrate how cost-effectiveness acceptability curves are constructed, what they represent and how they should be interpreted.




This article has been cited by other articles:


Home page
 EuropaceHome page
M. R. Cowie, D. Marshall, M. Drummond, N. Ferko, M. Maschio, M. Ekman, L. de Roy, H. Heidbuchel, Y. Verboven, F. Braunschweig, et al.
Lifetime cost-effectiveness of prophylactic implantation of a cardioverter defibrillator in patients with reduced left ventricular systolic function: results of Markov modelling in a European population
Europace, June 1, 2009; 11(6): 716 - 726.
[Abstract] [Full Text] [PDF]

Home page
 Evid. Based Ment. HealthHome page
B. Barrett and S. Byford
Economic evaluations in evidence based healthcare
Evid. Based Ment. Health, May 1, 2009; 12(2): 36 - 39.
[Full Text] [PDF]

Home page
 Evid. Based Nurs.Home page
M. Soares and J. C Dumville
Economic evaluation of healthcare technologies using primary research
Evid. Based Nurs., July 1, 2008; 11(3): 67 - 71.
[Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
S. Byford, B. Barrett, C. Roberts, P. Wilkinson, B. Dubicka, R. G. Kelvin, L. White, C. Ford, S. Breen, and I. Goodyer
Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive behavioural therapy in adolescents with major depression
The British Journal of Psychiatry, December 1, 2007; 191(6): 521 - 527.
[Abstract] [Full Text] [PDF]

Home page
 Br. J. PsychiatryHome page
S. BYFORD, B. BARRETT, C. ROBERTS, A. CLARK, V. EDWARDS, N. SMETHURST, and S. G. GOWERS
Economic evaluation of a randomised controlled trial for anorexia nervosa in adolescents
The British Journal of Psychiatry, November 1, 2007; 191(5): 436 - 440.
[Abstract] [Full Text] [PDF]

Home page
 BMJHome page
C. Flood, S. Byford, C. Henderson, M. Leese, G. Thornicroft, K. Sutherby, and G. Szmukler
Joint crisis plans for people with psychosis: economic evaluation of a randomised controlled trial
BMJ, October 7, 2006; 333(7571): 729.
[Abstract] [Full Text] [PDF]